Mr. Rankin's experience and insights into patient-provider subscription platforms make him a valued addition, likely aiding the success of Nanostics Inc.'s lead product, ClarityDX Prostate®. His background offers valuable industry perspective and strategic expertise.
NANOSONICS LIMITED股票討論區
暫無評論